Abstract
Background
Surgery of small-bowel neuroendocrine (SBNE) tumors is demanding because of the need for associated extensive node dissection and assessment of possible synchronous lesions. For this reason, possible benefit of laparoscopy in SBNE tumors has not been reported to date.
Methods
From 1996, all patients operated on in Beaujon Hospital for SBNE tumors were retrospectively extracted from a prospectively maintained database of intestinal resections.
Results
Overall, 73 patients [55 % males, median age 55 years (range 27–79)] underwent small bowel resection (n = 38; 54 %), ileocolectomy (n = 25; 36 %), or both (n = 7; 10 %). In 18 patients, resection of synchronous liver metastasis was performed simultaneously. Resection was performed laparoscopically in 12 patients (16 %). Resection was R0 in 40 patients (55 %), R1 in 1 patient (1 %), and R2 in 32 patients (44 %) because of unresectable liver metastases (n = 29), nodal involvement (n = 1), or both (n = 2). Laparoscopy was associated with similar R0 (p = 0.06) and morbidity (p = 0.95) rates, but a shorter hospital stay (p = 0.003) compared with laparotomy. Median follow-up was 39 months. Progression-free survival (PFS) at 1, 3, and 5 years were 95, 83 and 75 %, respectively, for R0 patients without liver metastasis; 92, 83, and 57 %, respectively, for R0 patients with resected liver metastasis; and 82, 58 and 30 %, respectively, for R2 patients (p = 0.045). Overall survival and PFS did not show any difference when comparing the laparoscopic and open groups.
Conclusion
Complete resection of primary SBNE tumors with or without liver metastasis is associated with good long-term survival. In selected patients, laparoscopy for SBNE tumors is feasible and associated with a shorter hospital stay than laparotomy.
Similar content being viewed by others
Abbreviations
- SBNE:
-
Small bowel neuroendocrine
- LM:
-
Liver metastases
- PFS:
-
Progression-free survival
- OS:
-
Overall survival
References
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE et al (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072
Bergestuen DS, Aabakken L, Holm K, Vatn M, Thiis-Evensen E (2009) Small intestinal neuroendocrine tumors: prognostic factors and survival. Scand J Gastroenterol 44:1084–1091
Modlin IM, Champaneria MC, Chan AK, Kidd M (2007) A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol 102:1464–1473
Zar N, Garmo H, Holmberg L, Rastad J, Hellman P (2004) Long-term survival of patients with small intestinal carcinoid tumors. World J Surg 28:1163–1168
Landerholm K, Zar N, Andersson RE, Falkmer SE, Jarhult J (2011) Survival and prognostic factors in patients with small bowel carcinoid tumour. Br J Surg 98:1617–1624
Panzuto F, Campana D, Fazio N, Brizzi MP, Boninsegna L, Nori F et al (2012) Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors. Neuroendocrinology 96:32–40
Eriksson B, Kloppel G, Krenning E, Ahlman H, Plockinger U, Wiedenmann B et al (2008) Consensus guidelines for the management of patients with digestive neuroendocrine tumors: well-differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology 87:8–19
Soreide O, Berstad T, Bakka A, Schrumpf E, Hanssen LE, Engh V et al (1992) Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 111:48–54
Hellman P, Lundstrom T, Ohrvall U, Eriksson B, Skogseid B, Oberg K et al (2002) Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg 26:991–997
Le Roux C, Lombard-Bohas C, Delmas C, Dominguez-Tinajero S, Ruszniewski P, Samalin E et al (2011) Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study. Dig Liver Dis 43:828–833
Nave H, Mossinger E, Feist H, Lang H, Raab H (2001) Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery 129:170–175
Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications. Ann Surg 240:205–213
Ma Y, Yang Z, Qin H, Wang Y (2011) A meta-analysis of laparoscopy compared with open colorectal resection for colorectal cancer. Med Oncol 28:925–933
Ohtani H, Tamamori Y, Arimoto Y, Nishiguchi Y, Maeda K, Hirakawa K (2011) A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for colorectal cancer. J Cancer 2:425–434
Jann H, Roll S, Couvelard A, Hentic O, Pavel M, Müller-Nordhorn J et al (2011) Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome. Cancer 117:3332–3341
Disclosures
Marleny N. Figueiredo, Sébastien Gaujoux, Léon Maggiori, Anne Couvelard, Nathalie Guedj, Philippe Ruszniewski, and Yves Panis have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Figueiredo, M.N., Maggiori, L., Gaujoux, S. et al. Surgery for small-bowel neuroendocrine tumors: Is there any benefit of the laparoscopic approach?. Surg Endosc 28, 1720–1726 (2014). https://doi.org/10.1007/s00464-013-3381-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-013-3381-x